BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17182661)

  • 21. Pre-operative diagnosis of breast cancer in screening: problems and pitfalls.
    Provenzano E; Pinder SE
    Pathology; 2009 Jan; 41(1):3-17. PubMed ID: 19089735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasive Lobular Carcinoma Mimicking Papillary Carcinoma: A Report of Three Cases.
    Rakha EA; Abbas A; Sheeran R
    Pathobiology; 2016; 83(5):221-7. PubMed ID: 27116593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolving concepts in the management of lobular neoplasia.
    Anderson BO; Calhoun KE; Rosen EL
    J Natl Compr Canc Netw; 2006 May; 4(5):511-22. PubMed ID: 16687097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast MRI: opportunities and challenges.
    Day D
    Minn Med; 2009 Dec; 92(12):45-8. PubMed ID: 20092173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
    Renshaw AA; Derhagopian RP; Martinez P; Gould EW
    Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sonographic Appearance of Lesions Diagnosed as Lobular Neoplasia at Sonographically Guided Biopsies.
    Ferré R; Omeroglu A; Mesurolle B
    AJR Am J Roentgenol; 2017 Mar; 208(3):669-675. PubMed ID: 28075608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
    Dabbs DJ; Schnitt SJ; Geyer FC; Weigelt B; Baehner FL; Decker T; Eusebi V; Fox SB; Ichihara S; Lakhani SR; Palacios J; Rakha E; Richardson AL; Schmitt FC; Tan PH; Tse GM; Vincent-Salomon A; Ellis IO; Badve S; Reis-Filho JS
    Am J Surg Pathol; 2013 Jul; 37(7):e1-11. PubMed ID: 23759937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Variants of breast lobular neoplasia: differential diagnosis and new molecular insight].
    Zhang Z; Zhang Y; Bu H; Tang P
    Zhonghua Bing Li Xue Za Zhi; 2022 Feb; 51(2):160-164. PubMed ID: 35152642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lobular neoplasia: morphology and management.
    Jorns J; Sabel MS; Pang JC
    Arch Pathol Lab Med; 2014 Oct; 138(10):1344-9. PubMed ID: 25268198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes.
    Singh K; Paquette C; Kalife ET; Wang Y; Mangray S; Quddus MR; Steinhoff MM
    Hum Pathol; 2018 Aug; 78():163-170. PubMed ID: 29753007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer.
    Liberman L; Morris EA; Dershaw DD; Abramson AF; Tan LK
    AJR Am J Roentgenol; 2003 Apr; 180(4):901-10. PubMed ID: 12646427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of fine-needle aspiration cytology and needle-core biopsy in the diagnosis of lobular carcinoma of the breast.
    Sadler GP; McGee S; Dallimore NS; Monypenny IJ; Douglas-Jones AG; Lyons K; Horgan K
    Br J Surg; 1994 Sep; 81(9):1315-7. PubMed ID: 7953397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Noninvasive breast carcinomas: anatomicopathological, diagnostic and therapeutic findings].
    Calabrese L
    Acta Biomed Ateneo Parmense; 1998; 69(3-4):113-21. PubMed ID: 10503071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lobular neoplasia: frequency and association with other breast lesions.
    Gomes DS; Balabram D; Porto SS; Gobbi H
    Diagn Pathol; 2011 Aug; 6():74. PubMed ID: 21827679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
    Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
    Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution.
    Li X; Ma Z; Styblo TM; Arciero CA; Wang H; Cohen MA
    Breast Cancer Res Treat; 2021 Feb; 185(3):573-581. PubMed ID: 33068196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast--a review.
    Hussain M; Cunnick GH
    Eur J Surg Oncol; 2011 Apr; 37(4):279-89. PubMed ID: 21306860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy.
    Berg WA; Mrose HE; Ioffe OB
    Radiology; 2001 Feb; 218(2):503-9. PubMed ID: 11161169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
    Renshaw AA; Gould EW
    Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lobular neoplasia: morphology, biological potential and management in core biopsies.
    O'Malley FP
    Mod Pathol; 2010 May; 23 Suppl 2():S14-25. PubMed ID: 20436498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.